chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Bilevel positive airway pressure, Bronchial disorder, Chest X-ray abnormal, Complications of transplanted lung, Delirium
Clinical narrative: Initial literature report received on 06 Sep 2010: This patient had history of end-stage lung disease secondary to alpha1-anti-trypsin deficiency and chronic obstructive pulmonary disease. After suitable organs became available, he was admitted for potential bilateral lung transplantation and was found to have ongoing shortness of breath associated with new-onset malaise, myalgia and other non-specific symptoms for 48 hours. The onset of these symptoms occurred shortly after he was given H1N1 (manufacturer unknown, influenza H1N1 vaccine, batch number not reported). His partial pressure of carbon dioxide (PCO2) was 72 mm Hg, partial pressure of oxygen (PO2) was 77 mm Hg and oxygen saturation (SaO2) was 94% on 10 liters of oxygen via nasal cannula. Prior to transplantation, he was transferred to the cardiovascular intensive care unit where his shortness of breath improved utilizing a BiPAP device, without the need for intubation and mechanical ventilation. Chest X-ray showed chronic emphysematous changes with mild increase in bronchovascular markings. The recent worsening in symptoms was attributed to a combination of severe underlying lung disease and a reaction to the vaccine. The decision was made to proceed with a transplant. However, as a precaution, nasopharyngeal swabs were obtained and empiric anti-viral therapy with TAMIFLU 150 mg twice a day was started immediately pre-operatively. He underwent bilateral lung transplantation on the day of admission. In the immediate post-operative period his nasopharyngeal swab came back positive for novel pandemic influenza H1N1 virus with the use of a real-time reverse transcript-polymerase chain reaction (RT-PCR) assay. The transplant procedure was well tolerated by the patient and he was extubated on the first today post-operatively. Postoperatively, two consecutive bronchoalveolar lavage samples from the transplanted lungs were positive for H1N1 virus. He received induction immunosuppression with anti-thymocyte globulin for the first 5 days along with mycophenolate mofetil and steroids. Tacrolimus was started on day 3 with the dose adjusted to maintain levels of around 10 ug/L to 15ug/L. Marked improvement in his condition was noticed and he was transferred to the ward. He developed some delirium postoperatively, mostly secondary to high tacrolimus levels, which resolved spontaneously. TAMIFLU was continued for a period of 14 days, and then replaced by inhaled RELENZA for another week. His chest X-ray post-operatively was satisfactory. He was discharged home in a good condition 3 weeks after bilateral lung transplantation and has remained well to date.
Age: 50.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Dyspnoea, Emphysema, Extubation, Influenza, Influenza A virus test positive
Clinical narrative: Initial literature report received on 06 Sep 2010: This patient had history of end-stage lung disease secondary to alpha1-anti-trypsin deficiency and chronic obstructive pulmonary disease. After suitable organs became available, he was admitted for potential bilateral lung transplantation and was found to have ongoing shortness of breath associated with new-onset malaise, myalgia and other non-specific symptoms for 48 hours. The onset of these symptoms occurred shortly after he was given H1N1 (manufacturer unknown, influenza H1N1 vaccine, batch number not reported). His partial pressure of carbon dioxide (PCO2) was 72 mm Hg, partial pressure of oxygen (PO2) was 77 mm Hg and oxygen saturation (SaO2) was 94% on 10 liters of oxygen via nasal cannula. Prior to transplantation, he was transferred to the cardiovascular intensive care unit where his shortness of breath improved utilizing a BiPAP device, without the need for intubation and mechanical ventilation. Chest X-ray showed chronic emphysematous changes with mild increase in bronchovascular markings. The recent worsening in symptoms was attributed to a combination of severe underlying lung disease and a reaction to the vaccine. The decision was made to proceed with a transplant. However, as a precaution, nasopharyngeal swabs were obtained and empiric anti-viral therapy with TAMIFLU 150 mg twice a day was started immediately pre-operatively. He underwent bilateral lung transplantation on the day of admission. In the immediate post-operative period his nasopharyngeal swab came back positive for novel pandemic influenza H1N1 virus with the use of a real-time reverse transcript-polymerase chain reaction (RT-PCR) assay. The transplant procedure was well tolerated by the patient and he was extubated on the first today post-operatively. Postoperatively, two consecutive bronchoalveolar lavage samples from the transplanted lungs were positive for H1N1 virus. He received induction immunosuppression with anti-thymocyte globulin for the first 5 days along with mycophenolate mofetil and steroids. Tacrolimus was started on day 3 with the dose adjusted to maintain levels of around 10 ug/L to 15ug/L. Marked improvement in his condition was noticed and he was transferred to the ward. He developed some delirium postoperatively, mostly secondary to high tacrolimus levels, which resolved spontaneously. TAMIFLU was continued for a period of 14 days, and then replaced by inhaled RELENZA for another week. His chest X-ray post-operatively was satisfactory. He was discharged home in a good condition 3 weeks after bilateral lung transplantation and has remained well to date.
Age: 50.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Intensive care, Lung disorder, Lung transplant, Malaise, Myalgia
Clinical narrative: Initial literature report received on 06 Sep 2010: This patient had history of end-stage lung disease secondary to alpha1-anti-trypsin deficiency and chronic obstructive pulmonary disease. After suitable organs became available, he was admitted for potential bilateral lung transplantation and was found to have ongoing shortness of breath associated with new-onset malaise, myalgia and other non-specific symptoms for 48 hours. The onset of these symptoms occurred shortly after he was given H1N1 (manufacturer unknown, influenza H1N1 vaccine, batch number not reported). His partial pressure of carbon dioxide (PCO2) was 72 mm Hg, partial pressure of oxygen (PO2) was 77 mm Hg and oxygen saturation (SaO2) was 94% on 10 liters of oxygen via nasal cannula. Prior to transplantation, he was transferred to the cardiovascular intensive care unit where his shortness of breath improved utilizing a BiPAP device, without the need for intubation and mechanical ventilation. Chest X-ray showed chronic emphysematous changes with mild increase in bronchovascular markings. The recent worsening in symptoms was attributed to a combination of severe underlying lung disease and a reaction to the vaccine. The decision was made to proceed with a transplant. However, as a precaution, nasopharyngeal swabs were obtained and empiric anti-viral therapy with TAMIFLU 150 mg twice a day was started immediately pre-operatively. He underwent bilateral lung transplantation on the day of admission. In the immediate post-operative period his nasopharyngeal swab came back positive for novel pandemic influenza H1N1 virus with the use of a real-time reverse transcript-polymerase chain reaction (RT-PCR) assay. The transplant procedure was well tolerated by the patient and he was extubated on the first today post-operatively. Postoperatively, two consecutive bronchoalveolar lavage samples from the transplanted lungs were positive for H1N1 virus. He received induction immunosuppression with anti-thymocyte globulin for the first 5 days along with mycophenolate mofetil and steroids. Tacrolimus was started on day 3 with the dose adjusted to maintain levels of around 10 ug/L to 15ug/L. Marked improvement in his condition was noticed and he was transferred to the ward. He developed some delirium postoperatively, mostly secondary to high tacrolimus levels, which resolved spontaneously. TAMIFLU was continued for a period of 14 days, and then replaced by inhaled RELENZA for another week. His chest X-ray post-operatively was satisfactory. He was discharged home in a good condition 3 weeks after bilateral lung transplantation and has remained well to date.
Age: 50.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Nonspecific reaction, Oxygen saturation decreased, PCO2 increased, PO2 decreased, Post procedural complication
Clinical narrative: Initial literature report received on 06 Sep 2010: This patient had history of end-stage lung disease secondary to alpha1-anti-trypsin deficiency and chronic obstructive pulmonary disease. After suitable organs became available, he was admitted for potential bilateral lung transplantation and was found to have ongoing shortness of breath associated with new-onset malaise, myalgia and other non-specific symptoms for 48 hours. The onset of these symptoms occurred shortly after he was given H1N1 (manufacturer unknown, influenza H1N1 vaccine, batch number not reported). His partial pressure of carbon dioxide (PCO2) was 72 mm Hg, partial pressure of oxygen (PO2) was 77 mm Hg and oxygen saturation (SaO2) was 94% on 10 liters of oxygen via nasal cannula. Prior to transplantation, he was transferred to the cardiovascular intensive care unit where his shortness of breath improved utilizing a BiPAP device, without the need for intubation and mechanical ventilation. Chest X-ray showed chronic emphysematous changes with mild increase in bronchovascular markings. The recent worsening in symptoms was attributed to a combination of severe underlying lung disease and a reaction to the vaccine. The decision was made to proceed with a transplant. However, as a precaution, nasopharyngeal swabs were obtained and empiric anti-viral therapy with TAMIFLU 150 mg twice a day was started immediately pre-operatively. He underwent bilateral lung transplantation on the day of admission. In the immediate post-operative period his nasopharyngeal swab came back positive for novel pandemic influenza H1N1 virus with the use of a real-time reverse transcript-polymerase chain reaction (RT-PCR) assay. The transplant procedure was well tolerated by the patient and he was extubated on the first today post-operatively. Postoperatively, two consecutive bronchoalveolar lavage samples from the transplanted lungs were positive for H1N1 virus. He received induction immunosuppression with anti-thymocyte globulin for the first 5 days along with mycophenolate mofetil and steroids. Tacrolimus was started on day 3 with the dose adjusted to maintain levels of around 10 ug/L to 15ug/L. Marked improvement in his condition was noticed and he was transferred to the ward. He developed some delirium postoperatively, mostly secondary to high tacrolimus levels, which resolved spontaneously. TAMIFLU was continued for a period of 14 days, and then replaced by inhaled RELENZA for another week. His chest X-ray post-operatively was satisfactory. He was discharged home in a good condition 3 weeks after bilateral lung transplantation and has remained well to date.
Age: 50.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Vaccination complication
Clinical narrative: Initial literature report received on 06 Sep 2010: This patient had history of end-stage lung disease secondary to alpha1-anti-trypsin deficiency and chronic obstructive pulmonary disease. After suitable organs became available, he was admitted for potential bilateral lung transplantation and was found to have ongoing shortness of breath associated with new-onset malaise, myalgia and other non-specific symptoms for 48 hours. The onset of these symptoms occurred shortly after he was given H1N1 (manufacturer unknown, influenza H1N1 vaccine, batch number not reported). His partial pressure of carbon dioxide (PCO2) was 72 mm Hg, partial pressure of oxygen (PO2) was 77 mm Hg and oxygen saturation (SaO2) was 94% on 10 liters of oxygen via nasal cannula. Prior to transplantation, he was transferred to the cardiovascular intensive care unit where his shortness of breath improved utilizing a BiPAP device, without the need for intubation and mechanical ventilation. Chest X-ray showed chronic emphysematous changes with mild increase in bronchovascular markings. The recent worsening in symptoms was attributed to a combination of severe underlying lung disease and a reaction to the vaccine. The decision was made to proceed with a transplant. However, as a precaution, nasopharyngeal swabs were obtained and empiric anti-viral therapy with TAMIFLU 150 mg twice a day was started immediately pre-operatively. He underwent bilateral lung transplantation on the day of admission. In the immediate post-operative period his nasopharyngeal swab came back positive for novel pandemic influenza H1N1 virus with the use of a real-time reverse transcript-polymerase chain reaction (RT-PCR) assay. The transplant procedure was well tolerated by the patient and he was extubated on the first today post-operatively. Postoperatively, two consecutive bronchoalveolar lavage samples from the transplanted lungs were positive for H1N1 virus. He received induction immunosuppression with anti-thymocyte globulin for the first 5 days along with mycophenolate mofetil and steroids. Tacrolimus was started on day 3 with the dose adjusted to maintain levels of around 10 ug/L to 15ug/L. Marked improvement in his condition was noticed and he was transferred to the ward. He developed some delirium postoperatively, mostly secondary to high tacrolimus levels, which resolved spontaneously. TAMIFLU was continued for a period of 14 days, and then replaced by inhaled RELENZA for another week. His chest X-ray post-operatively was satisfactory. He was discharged home in a good condition 3 weeks after bilateral lung transplantation and has remained well to date.
Age: 52.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: HLA marker study positive, Hyperglycaemia, Pancreas transplant rejection, Type 1 diabetes mellitus
Clinical narrative: Initial literature report received on 06 Sep 2010: This article deals with pancreas rejection after H1N1 vaccination or infection. This patient with type 1 diabetes mellitus underwent pancreas transplantation (portal-enteric drainage) using basiliximab induction and triple maintenance immunosuppression 09 and 05 years before, respectively from a cadaveric donor in Apr 2001. The patient was vaccinated with H1N1 (manufacturer and batch number unknown) in Dec 2009. After the vaccination, the patient experienced hyperglycemia, lost insulin independence and was diagnosed with acute rejection in Dec 2009. The repeat testing showed broad sensitization against more than 18 different human leukocyte antigen (HLA) class I and more than 13 human leukocyte antigen (HLA) class II antigens. It was reported that, no anti-HLA immunoglobulin G (IgG) evident in Jan 2009 and the patient never received blood component transfusions. The outcome of events was not reported.
Age: 42.0
Sex: M
Vaccine: FLU3, HEP
Symptoms: Abdominal discomfort, Asthenia, Back pain, Blood test abnormal, Electromyogram abnormal
Clinical narrative: WOKE UP IN THE MORNING WITH THE FEELING OF NUMB/TINGLING FEELING IN FEET. ON 10/19/2009 NUMBNESS/TINGLING MOVED UP INTO LEGS W/COLD AND HEAVINESS IN LEGS. ON 11/02/2009 WHILE WORKING, NUMB/TINGLING FEELING MOVED UP INTO THIGHS, STOMACH, BACK, HANDS. SEVERE BACK PAIN AND WEAKNESS. WAS TAKING TO ER.
Age: 42.0
Sex: M
Vaccine: FLU3, HEP
Symptoms: Hypoaesthesia, Influenza, Lumbar puncture abnormal, Nerve conduction studies abnormal, Nuclear magnetic resonance imaging abnormal
Clinical narrative: WOKE UP IN THE MORNING WITH THE FEELING OF NUMB/TINGLING FEELING IN FEET. ON 10/19/2009 NUMBNESS/TINGLING MOVED UP INTO LEGS W/COLD AND HEAVINESS IN LEGS. ON 11/02/2009 WHILE WORKING, NUMB/TINGLING FEELING MOVED UP INTO THIGHS, STOMACH, BACK, HANDS. SEVERE BACK PAIN AND WEAKNESS. WAS TAKING TO ER.
Age: 42.0
Sex: M
Vaccine: FLU3, HEP
Symptoms: Nuclear magnetic resonance imaging brain normal, Peripheral coldness
Clinical narrative: WOKE UP IN THE MORNING WITH THE FEELING OF NUMB/TINGLING FEELING IN FEET. ON 10/19/2009 NUMBNESS/TINGLING MOVED UP INTO LEGS W/COLD AND HEAVINESS IN LEGS. ON 11/02/2009 WHILE WORKING, NUMB/TINGLING FEELING MOVED UP INTO THIGHS, STOMACH, BACK, HANDS. SEVERE BACK PAIN AND WEAKNESS. WAS TAKING TO ER.
Age: 42.0
Sex: M
Vaccine: FLU3, HEP
Symptoms: Asthenia, Back pain, Blood test, Computerised tomogram, Electromyogram
Clinical narrative: WOKE UP IN THE MORNING WITH THE FEELING OF NUMB/TINGLING FEELING IN FEET. ON 10/19/2009 NUMBNESS/TINGLING MOVED UP INTO LEGS W/COLD AND HEAVINESS IN LEGS. ON 11/02/2009 WHILE WORKING, NUMB/TINGLING FEELING MOVED UP INTO THIGHS, STOMACH, BACK, HANDS. SEVERE BACK PAIN AND WEAKNESS. WAS TAKING TO ER.
Age: 42.0
Sex: M
Vaccine: FLU3, HEP
Symptoms: Hypoaesthesia, Lumbar puncture, Nerve conduction studies, Nuclear magnetic resonance imaging, Nuclear magnetic resonance imaging brain
Clinical narrative: WOKE UP IN THE MORNING WITH THE FEELING OF NUMB/TINGLING FEELING IN FEET. ON 10/19/2009 NUMBNESS/TINGLING MOVED UP INTO LEGS W/COLD AND HEAVINESS IN LEGS. ON 11/02/2009 WHILE WORKING, NUMB/TINGLING FEELING MOVED UP INTO THIGHS, STOMACH, BACK, HANDS. SEVERE BACK PAIN AND WEAKNESS. WAS TAKING TO ER.
Age: 42.0
Sex: M
Vaccine: FLU3, HEP
Symptoms: Paraesthesia, Peripheral coldness, Sensation of heaviness
Clinical narrative: WOKE UP IN THE MORNING WITH THE FEELING OF NUMB/TINGLING FEELING IN FEET. ON 10/19/2009 NUMBNESS/TINGLING MOVED UP INTO LEGS W/COLD AND HEAVINESS IN LEGS. ON 11/02/2009 WHILE WORKING, NUMB/TINGLING FEELING MOVED UP INTO THIGHS, STOMACH, BACK, HANDS. SEVERE BACK PAIN AND WEAKNESS. WAS TAKING TO ER.
Age: 3.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Acute respiratory distress syndrome, Anaemia, Beta haemolytic streptococcal infection, Blood culture negative, CSF glucose normal
Clinical narrative: Fever (101 to 104.5ax) x3 day, lethargy, no appetite, refusing po fluids, chills, diarrhea x1 episode on day 4. Respiratory distress on day 3. Hospitalized on day 4 with resp failure. Ventilated x1 week. Hospitalized X 6.5 weeks. IV antibiotics, spinal tap, EEG, MRI/MRA. Loss of neurological functioning.
Age: 3.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: CSF protein normal, CSF white blood cell count negative, Chest X-ray abnormal, Culture throat positive, Cytomegalovirus test negative
Clinical narrative: Fever (101 to 104.5ax) x3 day, lethargy, no appetite, refusing po fluids, chills, diarrhea x1 episode on day 4. Respiratory distress on day 3. Hospitalized on day 4 with resp failure. Ventilated x1 week. Hospitalized X 6.5 weeks. IV antibiotics, spinal tap, EEG, MRI/MRA. Loss of neurological functioning.
Age: 3.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Dyskinesia, Electroencephalogram abnormal, Encephalitis herpes, Encephalopathy, Endotracheal intubation
Clinical narrative: Fever (101 to 104.5ax) x3 day, lethargy, no appetite, refusing po fluids, chills, diarrhea x1 episode on day 4. Respiratory distress on day 3. Hospitalized on day 4 with resp failure. Ventilated x1 week. Hospitalized X 6.5 weeks. IV antibiotics, spinal tap, EEG, MRI/MRA. Loss of neurological functioning.
Age: 3.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Enterovirus test negative, Epilepsy, Epstein-Barr virus test negative, Escherichia infection, Extubation
Clinical narrative: Fever (101 to 104.5ax) x3 day, lethargy, no appetite, refusing po fluids, chills, diarrhea x1 episode on day 4. Respiratory distress on day 3. Hospitalized on day 4 with resp failure. Ventilated x1 week. Hospitalized X 6.5 weeks. IV antibiotics, spinal tap, EEG, MRI/MRA. Loss of neurological functioning.
Age: 3.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Grand mal convulsion, Intensive care, Lumbar puncture, Mental status changes, Mycoplasma test
Clinical narrative: Fever (101 to 104.5ax) x3 day, lethargy, no appetite, refusing po fluids, chills, diarrhea x1 episode on day 4. Respiratory distress on day 3. Hospitalized on day 4 with resp failure. Ventilated x1 week. Hospitalized X 6.5 weeks. IV antibiotics, spinal tap, EEG, MRI/MRA. Loss of neurological functioning.
Age: 3.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Nuclear magnetic resonance imaging abnormal, Pyrexia, Rash, Red blood cells CSF positive, Respiratory distress
Clinical narrative: Fever (101 to 104.5ax) x3 day, lethargy, no appetite, refusing po fluids, chills, diarrhea x1 episode on day 4. Respiratory distress on day 3. Hospitalized on day 4 with resp failure. Ventilated x1 week. Hospitalized X 6.5 weeks. IV antibiotics, spinal tap, EEG, MRI/MRA. Loss of neurological functioning.
Age: 3.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Stereotypy, Streptococcus test positive, Unresponsive to stimuli, Urinary tract infection, Viral test negative
Clinical narrative: Fever (101 to 104.5ax) x3 day, lethargy, no appetite, refusing po fluids, chills, diarrhea x1 episode on day 4. Respiratory distress on day 3. Hospitalized on day 4 with resp failure. Ventilated x1 week. Hospitalized X 6.5 weeks. IV antibiotics, spinal tap, EEG, MRI/MRA. Loss of neurological functioning.
Age: 3.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Vomiting
Clinical narrative: Fever (101 to 104.5ax) x3 day, lethargy, no appetite, refusing po fluids, chills, diarrhea x1 episode on day 4. Respiratory distress on day 3. Hospitalized on day 4 with resp failure. Ventilated x1 week. Hospitalized X 6.5 weeks. IV antibiotics, spinal tap, EEG, MRI/MRA. Loss of neurological functioning.
Age: 3.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Anaemia, Chills, Decreased appetite, Diarrhoea, Electroencephalogram abnormal
Clinical narrative: Fever (101 to 104.5ax) x3 day, lethargy, no appetite, refusing po fluids, chills, diarrhea x1 episode on day 4. Respiratory distress on day 3. Hospitalized on day 4 with resp failure. Ventilated x1 week. Hospitalized X 6.5 weeks. IV antibiotics, spinal tap, EEG, MRI/MRA. Loss of neurological functioning.
Age: 3.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Fluid intake reduced, Haemoglobin decreased, Immunology test normal, Laboratory test normal, Lethargy
Clinical narrative: Fever (101 to 104.5ax) x3 day, lethargy, no appetite, refusing po fluids, chills, diarrhea x1 episode on day 4. Respiratory distress on day 3. Hospitalized on day 4 with resp failure. Ventilated x1 week. Hospitalized X 6.5 weeks. IV antibiotics, spinal tap, EEG, MRI/MRA. Loss of neurological functioning.
Age: 3.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Lumbar puncture normal, Mechanical ventilation, Microbiology test normal, Nervous system disorder, Nuclear magnetic resonance imaging abnormal
Clinical narrative: Fever (101 to 104.5ax) x3 day, lethargy, no appetite, refusing po fluids, chills, diarrhea x1 episode on day 4. Respiratory distress on day 3. Hospitalized on day 4 with resp failure. Ventilated x1 week. Hospitalized X 6.5 weeks. IV antibiotics, spinal tap, EEG, MRI/MRA. Loss of neurological functioning.
Age: 3.0
Sex: F
Vaccine: VARCEL, VARCEL
Symptoms: Nuclear magnetic resonance imaging brain, Pyrexia, Respiratory distress, Respiratory failure, Rheumatoid factor
Clinical narrative: Fever (101 to 104.5ax) x3 day, lethargy, no appetite, refusing po fluids, chills, diarrhea x1 episode on day 4. Respiratory distress on day 3. Hospitalized on day 4 with resp failure. Ventilated x1 week. Hospitalized X 6.5 weeks. IV antibiotics, spinal tap, EEG, MRI/MRA. Loss of neurological functioning.
Age: 18.0
Sex: F
Vaccine: HEPA, HPV4, TDAP, HEPA, HPV4
Symptoms: Convulsion, Electroencephalogram abnormal
Clinical narrative: Information has been received from a physician and a licensed practical nurse concerning an 18 year old female patient with no pertinent medical history and no drug reactions or allergies who on 27-DEC-2007 was vaccinated IM with a 0.5ml first dose of GARDASIL (Lot # 659441/1446U) and concomitantly was vaccinated with a first dose of HAVRIX (Lot# AHAVB176AA). On 09-APR-2010, the patient received a second IM 0.5 ml dose of GARDSAIL (Lot# 661531/1311X) and concomitantly received a dose of MENACTRA (Lot# U2824AA). On 24-AUG-2009, the patient received the third IM 0.5 ml dose of GARDASIL (Lot# 662404/0312Y) and concomitantly received the second dose of HAVRIX (Lot# AHAVB334DA). Additional concomitant therapy included hormonal contraceptives (unspecified). The patient's neurologist reported that on 24-SEP-2009, the patient had a seizure and a second episode in October 2009 where the patient had twitching of limbs and a decrease of consciousness. She had had multiple seizures this summer. The patient was seen numerous times at the emergency room for her seizures but was not admitted to the hospital. The patient was referred to a neurologist. On 03-AUG-2010, the patient was started on therapy with KEPPRA. On 13-AUG-2010, the patient had an electroencephalography (EEG) which revealed generalized epilepsy. On 19-AUG-2010, the patient had a Gynecologist office visit. At the time of the report the patient had not recovered. The patient's generalized epilepsy were considered to be an other important medical event and disabling because the patient could not drive. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: HEPA, HPV4, TDAP, HEPA, HPV4
Symptoms: Convulsion, Depressed level of consciousness, Electroencephalogram abnormal, Grand mal convulsion, Impaired driving ability
Clinical narrative: Information has been received from a physician and a licensed practical nurse concerning an 18 year old female patient with no pertinent medical history and no drug reactions or allergies who on 27-DEC-2007 was vaccinated IM with a 0.5ml first dose of GARDASIL (Lot # 659441/1446U) and concomitantly was vaccinated with a first dose of HAVRIX (Lot# AHAVB176AA). On 09-APR-2010, the patient received a second IM 0.5 ml dose of GARDSAIL (Lot# 661531/1311X) and concomitantly received a dose of MENACTRA (Lot# U2824AA). On 24-AUG-2009, the patient received the third IM 0.5 ml dose of GARDASIL (Lot# 662404/0312Y) and concomitantly received the second dose of HAVRIX (Lot# AHAVB334DA). Additional concomitant therapy included hormonal contraceptives (unspecified). The patient's neurologist reported that on 24-SEP-2009, the patient had a seizure and a second episode in October 2009 where the patient had twitching of limbs and a decrease of consciousness. She had had multiple seizures this summer. The patient was seen numerous times at the emergency room for her seizures but was not admitted to the hospital. The patient was referred to a neurologist. On 03-AUG-2010, the patient was started on therapy with KEPPRA. On 13-AUG-2010, the patient had an electroencephalography (EEG) which revealed generalized epilepsy. On 19-AUG-2010, the patient had a Gynecologist office visit. At the time of the report the patient had not recovered. The patient's generalized epilepsy were considered to be an other important medical event and disabling because the patient could not drive. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: HEPA, HPV4, TDAP, HEPA, HPV4
Symptoms: Muscle twitching
Clinical narrative: Information has been received from a physician and a licensed practical nurse concerning an 18 year old female patient with no pertinent medical history and no drug reactions or allergies who on 27-DEC-2007 was vaccinated IM with a 0.5ml first dose of GARDASIL (Lot # 659441/1446U) and concomitantly was vaccinated with a first dose of HAVRIX (Lot# AHAVB176AA). On 09-APR-2010, the patient received a second IM 0.5 ml dose of GARDSAIL (Lot# 661531/1311X) and concomitantly received a dose of MENACTRA (Lot# U2824AA). On 24-AUG-2009, the patient received the third IM 0.5 ml dose of GARDASIL (Lot# 662404/0312Y) and concomitantly received the second dose of HAVRIX (Lot# AHAVB334DA). Additional concomitant therapy included hormonal contraceptives (unspecified). The patient's neurologist reported that on 24-SEP-2009, the patient had a seizure and a second episode in October 2009 where the patient had twitching of limbs and a decrease of consciousness. She had had multiple seizures this summer. The patient was seen numerous times at the emergency room for her seizures but was not admitted to the hospital. The patient was referred to a neurologist. On 03-AUG-2010, the patient was started on therapy with KEPPRA. On 13-AUG-2010, the patient had an electroencephalography (EEG) which revealed generalized epilepsy. On 19-AUG-2010, the patient had a Gynecologist office visit. At the time of the report the patient had not recovered. The patient's generalized epilepsy were considered to be an other important medical event and disabling because the patient could not drive. Additional information has been requested.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Chest X-ray normal, Chills, Cough, Dyspnoea, Full blood count normal
Clinical narrative: MYALGIAS REACTIVE AIRWAY SYMPTOMS SHORTNESS OF BREATH CHILLS COUGH
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Metabolic function test normal, Myalgia, Urine analysis normal
Clinical narrative: MYALGIAS REACTIVE AIRWAY SYMPTOMS SHORTNESS OF BREATH CHILLS COUGH
Age: 62.0
Sex: F
Vaccine: FLUX
Symptoms: Arthralgia, Chills, Dysgeusia, Pyrexia
Clinical narrative: Fever (up to 101.7), chills, joint pain, metallic taste in mouth.
Age: 10.0
Sex: M
Vaccine: FLUN3
Symptoms: Nasal inflammation, Rash macular, Rhinitis
Clinical narrative: Nostril was red and inflamed.  Splotchy skin under nose.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMRV
Symptoms: Oedema peripheral
Clinical narrative: Soft, palpable swelling under right arm. Mom reports that swelling is getting bigger.
Age: 63.0
Sex: M
Vaccine: FLU3, PPV, TDAP
Symptoms: Asthenia, Chills, Pain, Syncope
Clinical narrative: Pt. called office to report reaction after receiving Flu, Pneumonia & TDAP vaccines. C/o weakness, fainting, body aces, chills 24 hrs. after receiving shots.
Age: 23.0
Sex: M
Vaccine: FLU3
Symptoms: Chest discomfort
Clinical narrative: 6:15 - Patient give 0.5 ml Influenza vacc. IM. 9:00 - chest tightness & heaviness in throat. 10:15 - Patient reported to medical - pulse ox 99% - given 50 mL BENADRYL IM.
Age: 61.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Pain in extremity
Clinical narrative: Pain at site of injection, later pain at the left arm and leg.
Age: 18.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site reaction
Clinical narrative: Reaction at injection site skin looks red.
Age: 0.64
Sex: F
Vaccine: HIBV
Symptoms: Hypersensitivity, Rash generalised, Urticaria
Clinical narrative: Little small bumps or hives on legs.  The next morning she was covered from head to toe.  I took her back to the doctor and from there to the emergency room. Acute allergic reaction.
Age: 1.57
Sex: M
Vaccine: DTAP, HEPA, MMR, PNC13, VARCEL
Symptoms: Rash papular
Clinical narrative: Rash - small red papules, clustered about - torso & waist line.
Sex: U
Vaccine: FLU3
Symptoms: Headache, Hypoaesthesia, Restlessness
Clinical narrative: Head hurting, legs numb, restlessness, hand numb.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Furuncle, Herpes zoster
Clinical narrative: Patient presented to the clinic with a complaint of 3 "boils" on her buttocks. MD viewed 3 vesicles on left buttock, each about 3mm in size. Diagnosed with herpes zoster infection. Patient received herpes zoster vaccinations on 10/5/00 at the age of 15 months and on 10/15/09 at the age of 10 years.
Age: 64.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Erythema, Oedema peripheral
Clinical narrative: Swelling, redness (L) arm.
Age: 85.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: Patient called pharmacy on 9/13/10 and said her arm hurt and painful and she have not seen by Dr.
Age: 68.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Cellulitis, Erythema, Pain, Swelling
Clinical narrative: Patient experienced redness, swelling & soreness. Redness was spreading down patients arm. Patient went to urgent care & was diagnosed with cellulitis & is currently on a course of antibiotics.
Age: 11.0
Sex: F
Vaccine: FLU(H1N1)
Symptoms: Chorea, Movement disorder, Myositis, Neuritis, Polyarthritis
Clinical narrative: Pt developed movement disorder (eyes like mvts) myositis, neuritis with polyarthritis at 20-25 days after receiving the H1N1 vaccine on 12-8-9.
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Drooling, Dyspnoea, Hypoaesthesia, Paraesthesia, Swelling face
Clinical narrative: Information has been received from a physician concerning a 14 year old female patient with allergy to "sculsa" who on 01-SEP-2010 was vaccinated intramuscularly with her first dose of GARDASIL (lot#666162/0565Z). The physician stated that the patient got her vaccine and 20 minutes later while in her mother's car the patient began feeling tingling, numbness, swelling of the face, drooling and difficulty breathing, so her mother called 911. The patient was rushed to emergency room (E.R.), but not was hospitalized. At the time of report, the patient's outcome was unknown. Feeling tingling, numbness, swelling of the face, drooling and difficulty breathing were considered to be other important medical events by the physician. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Arthritis, Autism, Deafness neurosensory, Diabetes mellitus, Epilepsy
Clinical narrative: It was reported in a newspaper article, initial information was received on 29-AUG-2010 regarding that a group of parents who brought a case in 1993 which was blocked after their legal aid was withdrawn in 2003. They claimed for various injuries including autism, Guillain-Barre syndrome, epilepsy, sensorineural deafness, diabetes and arthritis. The status of the patients was unknown. Upon internal review, the autism, sensorineural deafness, epilepsy and Guillain-Barre syndrome are considered to be other important medical events.
Sex: U
Vaccine: MMR
Symptoms: Guillain-Barre syndrome
Clinical narrative: It was reported in a newspaper article, initial information was received on 29-AUG-2010 regarding that a group of parents who brought a case in 1993 which was blocked after their legal aid was withdrawn in 2003. They claimed for various injuries including autism, Guillain-Barre syndrome, epilepsy, sensorineural deafness, diabetes and arthritis. The status of the patients was unknown. Upon internal review, the autism, sensorineural deafness, epilepsy and Guillain-Barre syndrome are considered to be other important medical events.
Age: 7.0
Sex: M
Vaccine: FLU3
Symptoms: Complex partial seizures, Convulsion, Irritability
Clinical narrative: Received FLUZONE 9/11. Cranky on 9/12 and started seizing at 5AM on 9/12. Was given DIASTAT 5 mg rectal. Seized for one hour - partial/complex. During that time he also was talking but not making sense. No problem since then. No fever.
Age: 83.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Nausea, Pain
Clinical narrative: Nausea, body aches.
Age: 70.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Chills, Dyspnoea, Fatigue, Feeling abnormal
Clinical narrative: Patient called on 09/14/10 stating she got weak, chills, short of breath, pain in arms, fatigue after receiving flu shot on 9/10/10. Started feeling bad at 1:30pm on 9/10/10. Felt better 9/11/10 in afternoon. No local reaction (stated).
Age: 70.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: Patient called on 09/14/10 stating she got weak, chills, short of breath, pain in arms, fatigue after receiving flu shot on 9/10/10. Started feeling bad at 1:30pm on 9/10/10. Felt better 9/11/10 in afternoon. No local reaction (stated).
Age: 56.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site pain, Injection site swelling, Joint range of motion decreased
Clinical narrative: Pain at site of injection with pain & swelling up into the shoulder, (L) arm, no redness or heat. Limitation of range of motion of (L) arm. Ice applied. TYLENOL taken by patient.
Age: 42.0
Sex: M
Vaccine: MMR
Symptoms: Hypoaesthesia, Injection site pain, Pain
Clinical narrative: MMR to L arm on 8/2/10. 1-2 days numb fingers (palm side) and pain down (L) side, to ER 8/16/10 given pain meds. 8/23 not resolved yet- can't lay on (L) side- numb fingers & side and deltoid area pain. No noticeable swelling in deltoid area today pain when cross arm to (R) shoulder.
Age: 25.0
Sex: M
Vaccine: TTOX
Symptoms: Back pain, Blood test normal, Computerised tomogram head, Computerised tomogram normal, Dizziness
Clinical narrative: Pain and tingling on top and back of head, pain in lumbar area of back, muscle weakness, nausea, dizziness.
Age: 25.0
Sex: M
Vaccine: TTOX
Symptoms: Headache, Muscular weakness, Nausea, Paraesthesia
Clinical narrative: Pain and tingling on top and back of head, pain in lumbar area of back, muscle weakness, nausea, dizziness.
Age: 47.0
Sex: F
Vaccine: FLU3
Symptoms: Influenza like illness, Injection site erythema, Injection site swelling
Clinical narrative: injection site red and swollen and pt had flu like symtoms
Age: 1.51
Sex: F
Vaccine: PNC13, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Vaccination site warmth
Clinical narrative: Red bump warm to touch developed at spot of vaccination site.
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Decreased appetite, Fatigue, Injection site pain, Pain in extremity, Vomiting
Clinical narrative: Loss of appetite on 8/31/10 at dinner, complaining of very sore arms. In the morning she said she was very tired then she vomited. She only vomited once that day, no fever. She remained tired that morning but by afternoon she was back to herself.
Age: 65.0
Sex: F
Vaccine: FLU3
Symptoms: Body temperature increased, Chills, Feeling abnormal, Nausea
Clinical narrative: temperature of 101, severe chills, nausea, feeling very poorly overall, went to ER at the advice of an RN
Age: 54.0
Sex: F
Vaccine: TDAP
Symptoms: Muscle tightness
Clinical narrative: INCAPACITATING MUSCLE TIGHTNESS BILATERAL NECK & SHOULDERS, RADIATING DOWN BACK; TX SOMA, AP&P WITH CODEINE; X 3 DAYS; IBUPROFEN FOURTH AND FIFTH DAY
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Angiogram normal, Blood test normal, Catheterisation cardiac normal, Chest discomfort, Coronary artery occlusion
Clinical narrative: I received 2010-2011 seasonal flu shot here at the medical center last Tuesday (9-7-10 around 1:30 PM). I did not take the H1N1 vaccine last year so this was my first time taking the vaccine.  That night, Tuesday night,(09/07/2010 around 7:30 PM) I started feeling tightness in my chest and was short of breath.  I told both my children that if the tightness got worse or if I felt any type of pain, that I was going to the ER.  It did not get worse, but the tightness continued throughout the next day up into the afternoon.  I called my PCP and was told that I should go to the ER.  I did, I went to the ER here at the medical center and was kept overnight so they could do a stress test the next morning. All labs and EKG were normal. The next morning the cardiologist thought we should do an angiogram in lieu of a stress test to make sure my stents were still open and functioning.  I had the angiogram and everything looked good, only 20% blockage.  Then I was sent home.   I continued to have a little shortness of breath and occasional tight feeling in my chest for about a week. For six years I have had no problems with my heart, but shortly after taking the vaccine, I felt like I was headed for another heart attack.  I took the shot around 1:30 PM on Tuesday 9/7/10 and the chest tightness and shortness of breath started around 7:30 PM 9/7/10 (about six hours later).
Age: 57.0
Sex: F
Vaccine: FLU3
Symptoms: Dyspnoea, Electrocardiogram normal
Clinical narrative: I received 2010-2011 seasonal flu shot here at the medical center last Tuesday (9-7-10 around 1:30 PM). I did not take the H1N1 vaccine last year so this was my first time taking the vaccine.  That night, Tuesday night,(09/07/2010 around 7:30 PM) I started feeling tightness in my chest and was short of breath.  I told both my children that if the tightness got worse or if I felt any type of pain, that I was going to the ER.  It did not get worse, but the tightness continued throughout the next day up into the afternoon.  I called my PCP and was told that I should go to the ER.  I did, I went to the ER here at the medical center and was kept overnight so they could do a stress test the next morning. All labs and EKG were normal. The next morning the cardiologist thought we should do an angiogram in lieu of a stress test to make sure my stents were still open and functioning.  I had the angiogram and everything looked good, only 20% blockage.  Then I was sent home.   I continued to have a little shortness of breath and occasional tight feeling in my chest for about a week. For six years I have had no problems with my heart, but shortly after taking the vaccine, I felt like I was headed for another heart attack.  I took the shot around 1:30 PM on Tuesday 9/7/10 and the chest tightness and shortness of breath started around 7:30 PM 9/7/10 (about six hours later).
Age: 0.3
Sex: F
Vaccine: DTAP
Symptoms: Allergy test negative, Respiratory arrest, Vomiting
Clinical narrative: This case was reported by a consumer (the subject's mother) and described the occurrence of stopped breathing in a 3-month-old female subject who was vaccinated with DTAP vaccine, (manufacturer unspecified).  A physician or other health care professional has not verified this report.  The subject's medical history included low birth weight and prematurity.  Previous vaccination included hepatitis B vaccine recombinant; manufacturer unspecified; unknown given on an unspecified date.  On an unspecified date in 2005 the subject received 1st dose of DTAP vaccine (details unknown).  On an unspecified date in 2005, the same year after vaccination with DTAP vaccine, the subject experienced stopped breathing and vomiting.  The consumer reported that after the DTAP vaccine, the subject stopped breathing and was revived in the hospital.  The subject then developed vomiting for several days afterwards.  The subject did not develop hives or swelling.  The subject was hospitalised.  On an unspecified date in 2005, the events were resolved.  The vaccination course with DTAP vaccine was discontinued.  The consumer reported that the subject has since been able to receive the remainder of her childhood vaccinations with the exception of the DTAP series, and none of the other vaccinations resulted in any adverse events.  Allergy testing had not revealed the cause of the reaction.  The consumer was not sure which DTAP vaccine the subject received and she refused permission to follow-up.  No further information is available.
Age: 30.0
Sex: M
Vaccine: SMALL
Symptoms: Aspartate aminotransferase increased, Catheterisation cardiac, Chills, Headache, Influenza like illness
Clinical narrative: 9/7/10 Onset symptoms flu-like: fever (101.6), body aches, shills HA x 24 hours. Pt exam enlarged, lymph nodes, submand, cervical , supra cervical. No axillary enlg nodes, negative findings for heart/lung; ENT; bulging TM, left. Labs revealed possible pyelonephritis/BTELS. Pt sent to ER same day. Chief complaint is: fever, bodyaches, headaches x 24 hours.
Age: 30.0
Sex: M
Vaccine: SMALL
Symptoms: Laboratory test, Liver function test abnormal, Lymphadenopathy, Pain, Pyrexia
Clinical narrative: 9/7/10 Onset symptoms flu-like: fever (101.6), body aches, shills HA x 24 hours. Pt exam enlarged, lymph nodes, submand, cervical , supra cervical. No axillary enlg nodes, negative findings for heart/lung; ENT; bulging TM, left. Labs revealed possible pyelonephritis/BTELS. Pt sent to ER same day. Chief complaint is: fever, bodyaches, headaches x 24 hours.
Age: 30.0
Sex: M
Vaccine: SMALL
Symptoms: Tympanic membrane disorder, Ultrasound liver
Clinical narrative: 9/7/10 Onset symptoms flu-like: fever (101.6), body aches, shills HA x 24 hours. Pt exam enlarged, lymph nodes, submand, cervical , supra cervical. No axillary enlg nodes, negative findings for heart/lung; ENT; bulging TM, left. Labs revealed possible pyelonephritis/BTELS. Pt sent to ER same day. Chief complaint is: fever, bodyaches, headaches x 24 hours.
Age: 18.0
Sex: F
Vaccine: HEPA, HPV4
Symptoms: Fall, Foaming at mouth, Gaze palsy, Heart rate decreased, Hypotension
Clinical narrative: 30 seconds after receiving vaccine, she fell over to the side, her eyes rolled back in her head and she had some foaming at the mouth and was pale. She came to in about 1 min and was smiling and coherent. Pulse ox 100, pulse 43 (which came up over time). BP 80/60, after 30 min was 102/60.
Age: 18.0
Sex: F
Vaccine: HEPA, HPV4
Symptoms: Pallor
Clinical narrative: 30 seconds after receiving vaccine, she fell over to the side, her eyes rolled back in her head and she had some foaming at the mouth and was pale. She came to in about 1 min and was smiling and coherent. Pulse ox 100, pulse 43 (which came up over time). BP 80/60, after 30 min was 102/60.
Age: 70.0
Sex: M
Vaccine: FLU3
Symptoms: Dizziness
Clinical narrative: I woke up at 7 AM and as I got out of bed I suffered a severy dizzy spell. Thought it was just a passing incident.  I saw a cardiologist on August 30th who prescribed Meclizine for 30 days with one tab 3 times a day. The dizziness continues and I have seen my family clininc PA who thinks my problem may be Positional Vertigo and has referred me to an ENT doctor; Awaiting appointment.
Age: 6.0
Sex: M
Vaccine: FLUN3
Symptoms: Dysstasia, Fall, Incoherent, Lethargy, Malaise
Clinical narrative: At the doctors office patient was given Flu Mist, Then a TB test, he was scared and moved, then the nurse had to do a second one.  We stood up to leave and he fell to the floor and could not stand.  Said " I can't stand" I picked him up laid him on the table and his face was pale, his eyes unfocused and he was incoherent, I told the nurse to get the doctor.  Patient then said he was going to be sick.  He vomited for about 15 minutes then laid down, the doctor had his blood preassure checked and the nurse check his oxygen and about 20 minutes later he felt better.  But he was lethargic for another 2 hours ate little to no food the rest of the day but was better by bed time.
Age: 6.0
Sex: M
Vaccine: FLUN3
Symptoms: Pallor, Vision blurred, Vomiting
Clinical narrative: At the doctors office patient was given Flu Mist, Then a TB test, he was scared and moved, then the nurse had to do a second one.  We stood up to leave and he fell to the floor and could not stand.  Said " I can't stand" I picked him up laid him on the table and his face was pale, his eyes unfocused and he was incoherent, I told the nurse to get the doctor.  Patient then said he was going to be sick.  He vomited for about 15 minutes then laid down, the doctor had his blood preassure checked and the nurse check his oxygen and about 20 minutes later he felt better.  But he was lethargic for another 2 hours ate little to no food the rest of the day but was better by bed time.
Age: 45.0
Sex: F
Vaccine: PPV
Symptoms: Immediate post-injection reaction, Injection site erythema, Injection site swelling
Clinical narrative: Almost immediate swelling and redness around the injection site which moved down to elbow.
Age: 24.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: red and swelling around injection site
Age: 1.59
Sex: F
Vaccine: HEP, MMR
Symptoms: Pyrexia, Rash
Clinical narrative: diffused rash and fever
Age: 50.0
Sex: F
Vaccine: FLU3, TDAP
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: 9/14/2010 pt. reports received Tdap to left arm on 9/09/2010.  Vaccine site was fine until 9/11/10 when she noticed the site is hard, red and warm and about the size of a quarter.  States it's about the same or better today, no worse. Advised to F/U with PMD if no improvement.
Age: 0.45
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13
Symptoms: Hypotonic-hyporesponsive episode, Tremor
Clinical narrative: After vaccine administration, mom stayed in exam room to nurse the infant.  While nursing she noticed he was shaking.  She layed him on the exam table where she saw his arms shaking and he "was not acting right".  She called the nurse who notified me.  At my exam he was hypotonic and hyporesponsive.  Pulse ox. 96%, HR 130's, RR 14.  HHE lasted approximately 5 minutes after which he was smiling, cooing, and behaving normally.